| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/14/2005 | US6905687 Fusion proteins; immunogens; solid phase synthesis; kits |
| 06/14/2005 | US6905676 Cytokines; anttumor agents; viricides; bactericides; antiinflammatory agents |
| 06/14/2005 | US6905671 Using isotope of 5-aminolevulinic acid |
| 06/14/2005 | CA2333703C Isothiazole derivatives useful as anticancer agents |
| 06/14/2005 | CA2308142C Anti-idiotype monoclonal antibodies, their use in active immunotherapy of malignant tumors and compositions containing them |
| 06/14/2005 | CA2246708C Vaccine for b-cell malignancies |
| 06/11/2005 | CA2487578A1 Prognostic markers for prediction of treatment response and/or survival of breast cell proliferative disorder patients |
| 06/09/2005 | WO2005051955A1 Novel compound and medicinal composition |
| 06/09/2005 | WO2005051406A1 Ceramidase inhibitor |
| 06/09/2005 | WO2005021003A3 Immunosuppressive effects of pteridine derivatives |
| 06/09/2005 | WO2005009434A3 Compounds and methods for inducing apoptosis in cancer cells |
| 06/09/2005 | WO2005003335A3 Rapamycin resistant t cells and therapeutic uses thereof |
| 06/09/2005 | WO2004080421A3 Improved antitumoral treatments |
| 06/09/2005 | WO2004043956A8 Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same |
| 06/09/2005 | WO2004035629A8 Taxanes covalently bounded to hyaluronic acid or hyaluronic acid derivatives |
| 06/09/2005 | WO2003084302A3 Anti-aging agent |
| 06/09/2005 | US20050125846 Expression vector comprising nucleotide sequences coding transmembrant transport protein for use in diagnosis, treatment and prevention of thyroid disorders |
| 06/09/2005 | US20050124787 Process for preparing water soluble phosphonooxymethyl derivatives of alcohol and phenol |
| 06/09/2005 | US20050124697 Topical applying to skins; sunscreen agents; anticancer agents; using arylpropionic acid |
| 06/09/2005 | US20050124696 Cyclopenteneones for antiischemic agents, antiinflammatory agents and aging resistance |
| 06/09/2005 | US20050124682 Such as N-{2-[5-(methylthio)-1H-indol-3-yl]ethyl}acetamide for treatment of disorders of the melatoninergic system; hormone replacement therapy |
| 06/09/2005 | US20050124672 Antineoplastic agents, analgesics, antipyretics; prostaglandin E2 receptor antagonists; 3-Methyl-4-[6-[N-isobutyl-N-(2-thiazolylsulfonyl)amino]indan-5-yloxymethyl]benzoic acid, a C1-4 alkyl ester, or a non-toxic salt |
| 06/09/2005 | US20050124665 Cyclopenteneones for antiischemic agents, antiinflammatory agents and aging resistance |
| 06/09/2005 | US20050124649 Deazapurines and uses thereof |
| 06/09/2005 | US20050124648 Triazolo-quinolin derivatives useful as adenosine receptor ligands |
| 06/09/2005 | US20050124647 For example, 4-hydroxy-1,1-di-(5',6'-methylendioxy-indol-2-yl)-butane; antitumor agents, particularly for treating mammary carcinoma and colon carcinoma |
| 06/09/2005 | US20050124643 Steroid 3-O-sulphamate derivatives as inhibitors of oestrone sulphatase |
| 06/09/2005 | US20050124631 For example, 2-amino-7-chloro-6-hydroxy-4-methylbenzothiazole; compounds that prevent the formation of polyglutamine containing protein aggregates; treatment of spinal and bulbar muscular atrophy, dentatorubal pallidoluysian atrophy, spinocerebellar ataxia, Alzheimers disease |
| 06/09/2005 | US20050124621 Novel inhibitors of kinases |
| 06/09/2005 | US20050124615 3-heteroarly-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b] indole-1-acetamide derivatives, preparation and use thereof in medicaments |
| 06/09/2005 | US20050124605 E.g., substituted 2,3,5,10b-tetraaza-benzo[e]azulen-6-yl)-acetic acids, 2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepin-5-yl)-(4,6-dimethoxy-pyrimidin-2-yloxy)-acetic acids and 2,3,4,5-tetrahydro-benzo[e][1,4]diazepin-1-ylmethyl}-benzoates; treating circulatory, inflammatory, and proliferative disorders |
| 06/09/2005 | US20050124604 E.g. 1-Benzyl-4-[4-(thiophene-2-carbonyl) piperazin-1-yl]-2-oxo-1,2-dihydro-3-cyano[1,8]-naphthyridine; antinflammatory, -arthritic, -carcinogenic, -tumor, -diabetic agents; septic shock; acute respiratory distress syndrome; casrdiovascular disorders; angiogenesis inhibitors; autoimmune diseases; asthma |
| 06/09/2005 | US20050124599 Novel benzoimidazole derivatives useful as antiproliferative agents |
| 06/09/2005 | US20050124589 New use, pharmaceutical preparations as well as a process for their production |
| 06/09/2005 | US20050124585 Which contain phosphoramidate linkages; for retroviral or hepadnaviral therapy; for treatment of HIV/aquired immunodeficiency syndrome; antitumor agents; improved bioavailability |
| 06/09/2005 | US20050124584 Prodrugs of phosphonate nucleotide analogues |
| 06/09/2005 | US20050124583 Prodrugs of phosphonate nucleotide analogues |
| 06/09/2005 | US20050124577 8-Azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient |
| 06/09/2005 | US20050124549 Method of modulating the proliferation of medullary thyroid carcinoma cells |
| 06/09/2005 | US20050124543 Heterologous polypeptide of the TNF family |
| 06/09/2005 | US20050124537 Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein |
| 06/09/2005 | US20050124050 Osteoclast differentiation inhibitors |
| 06/09/2005 | US20050124005 Use of a labeled ligand having human cd4 specificity for producing a diagnostic used in the analysis of migration and/or distribution patterns of cell populations |
| 06/09/2005 | US20050123983 Methods and compositions for overcoming resistance to biologic and chemotherapy |
| 06/09/2005 | US20050123912 Nucleoprotein for use as tool in treatment, diagnosis and prevention of infection, cell proliferative, neurological, developmental, autoimmune and inflammatory disorders |
| 06/09/2005 | US20050123909 Compositions and methods for treating cells having double minute dna |
| 06/09/2005 | US20050123671 Incorporating trehalose into an edible aqueous system containing alpha glucosyl hesperidin or catechin or both followed by sterilization |
| 06/09/2005 | US20050123633 Obtained by fermenting soybean germ, which is used as raw material, with koji mold, thus breaking down proteins, then hydrolyzing, extracting and concentrating using solvent to produce an isoflavone aglycone concentrate |
| 06/09/2005 | US20050123623 Pharmaceutical compositions and their use in the treatment of neoplastic disease |
| 06/09/2005 | US20050123613 Used for intravenous transfusion; compatibility with tissues, have no toxicity or side effect, have no harmful stimulation, have no immunogenicity |
| 06/09/2005 | US20050123605 Anticancer agents; prevent forming blood vessels; removal blockage |
| 06/09/2005 | US20050123597 Releasable linkage and compositions containing same |
| 06/09/2005 | US20050123576 Mupirocin compositions for topical use, an improved process of making same and methods of using same |
| 06/09/2005 | US20050123575 Heating, cooling, reheating and recooling a mixture containing hard fat while stirring; cosmetics, cosmeceutical, pharmaceutical; second temperature is lower than the congelation temperature of the mixture; hard fat is a mixture of triester of glycerin with caprylic, capric and stearic acids |
| 06/09/2005 | US20050123558 Modifeid polypeptide |
| 06/09/2005 | US20050123551 Nucleic acids encoding polypeptides present in normal and neoplastic endometrial cells for use in diagnosis and treatment of endometrial cancer, identifying endometrial tissue; vectors, host cells; vaccines against endometrial cancer |
| 06/09/2005 | US20050123541 Anti-TNF antibodies, compositions, methods and uses |
| 06/09/2005 | US20050123536 Treatment of immunological disorders using anti-dc30 antibodies |
| 06/09/2005 | US20050123523 Immunostimulatory nucleic acid molecules |
| 06/09/2005 | US20050123513 Use of a reovirus for the manufacture of a medicament for treating a Ras-mediated neoplasm; administering reovirus to a Ras-mediated neoplasm without the side effects associated with other forms of cancer therapy; anticancer |
| 06/09/2005 | US20050123512 Binding agents, vectors, host cells; gene therapy; nucleotide sequence with DNA insert encoding polypeptide; genetic engineering; medical diagnosis |
| 06/09/2005 | US20050123508 human granulocyte colony stimulating factor polypeptides having amino acid replacements in the sequence, used for treating hematopoietic, neurological or reproductive disorders |
| 06/09/2005 | US20050123473 Diagnosis, therapy, image of celluloar disorders; antitumor agents |
| 06/09/2005 | DE10260618B4 Tumorhemmende annellierte Azepinonderivate Tumor-inhibiting fused Azepinonderivate |
| 06/09/2005 | CA2552553A1 Method of detecting liver cancer, diagnostic for liver cancer and remedy for cancer |
| 06/09/2005 | CA2547446A1 Solid forms of anti-egfr-antibodies |
| 06/09/2005 | CA2547275A1 Platinum(ii) complexes, preparation and use |
| 06/09/2005 | CA2547235A1 T-type calcium channel blocker |
| 06/09/2005 | CA2546932A1 Quinazolinone compounds as anticancer agents |
| 06/09/2005 | CA2546763A1 Epha2 agonistic monoclonal antibodies and methods of use thereof |
| 06/09/2005 | CA2546747A1 Ttbks as modifiers of the beta catenin pathway and methods of use |
| 06/09/2005 | CA2546677A1 Pharmaceutical formulations for the sustained release of interferons and therapeutic applications thereof |
| 06/09/2005 | CA2545478A1 Indolyl-thieno'3,4-bipyrazin-3-one derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
| 06/09/2005 | CA2545262A1 Quinazoline derivatives |
| 06/08/2005 | EP1538209A2 Self-assembling recombinant hpv16 papillomavirus capsid proteins |
| 06/08/2005 | EP1538202A2 Production of human alpha-galactosidase A |
| 06/08/2005 | EP1537878A1 Immunopotentiating compositions |
| 06/08/2005 | EP1537872A1 Immunostimulator having antineoplastic action and method for producing said immunostimulator |
| 06/08/2005 | EP1537871A1 Enoxaparin for the treatment of cancer |
| 06/08/2005 | EP1537870A2 Methods and compositions for treating cancer |
| 06/08/2005 | EP1537861A2 Use of aminothiol compounds for the treatment xerostomia caused by therapeutic agents or radiation |
| 06/08/2005 | EP1537857A1 Mupirocin compositions for topical use, a process of making same and uses thereof |
| 06/08/2005 | EP1537417A2 Method of diagnosing colon and gastric cancers |
| 06/08/2005 | EP1537219A2 Activation of tumor-reactive lymphocytes via antibodies or genes recognizing cd3 or 4-1bb |
| 06/08/2005 | EP1537203A1 USE OF DENDRITIC CELLS (DCs) EXPRESSING INTERLEUKIN 12 (IL-12) |
| 06/08/2005 | EP1537147A2 Antibody for adcc and inducing cytokine production |
| 06/08/2005 | EP1537138A2 Receptors and membrane-associated proteins |
| 06/08/2005 | EP1537129A1 Akt inhibitors, pharmaceutical compositions, and uses thereof |
| 06/08/2005 | EP1537112A1 Condensed pyridines and pyrimidines with tie2 (tek) activity |
| 06/08/2005 | EP1537108A1 Di and trifluoro-triazolo-pyridines anti-inflammatory compounds |
| 06/08/2005 | EP1537106A1 Dihydropyrazolopyridine compounds |
| 06/08/2005 | EP1537105A2 Synthesis of indolizines |
| 06/08/2005 | EP1537096A2 Derivatives of dioxane-2-alkyl carbamates, preparation method thereof and application of same in therapeutics |
| 06/08/2005 | EP1537087A1 Novel aminoindazole derivatives as medicines and pharmaceutical compositions containing same |
| 06/08/2005 | EP1537084A1 Substituted 2-alkylamine nicotinic amide derivatives and use there of |
| 06/08/2005 | EP1537075A2 Diarylurea derivatives and their use as chloride channel blockers |
| 06/08/2005 | EP1537074A1 Cathepsin cysteine protease inhibitors |
| 06/08/2005 | EP1537073A2 Benzamide or phenylacetamide derivatives useful as thyroid receptor ligands |
| 06/08/2005 | EP1537066A2 Improvements in pharmaceutically useful compounds |
| 06/08/2005 | EP1536864A2 Platinum complexes as antitumor agents in combination with biochemical modulation |